For many years, the pharmacological activity of nicotine alkaloid was closely related to the recreational use of tobacco products. But the paradigm is rapidly changing in today’s medical and pharmaceutical industries. Nowadays, comprehensive scientific studies are helping to redefine this powerful alkaloid as a unique tool for targeted therapy. The exploration of nicotine alkaloid pharmaceutical uses has gained momentum worldwide and gone beyond the narrow scope of smoking cessation. With more medical applications discovered by formulation specialists, the need for extremely high quality raw material has grown. Providing such crucial APIs entails impeccable chemistry. Prism Industries Pvt. Ltd. is one of the leading companies in this sphere and can be defined as a highly advanced and compliant global producer of clinical grade nicotine. The Opportunities: Expanding Therapeutic Horizons Indeed, the healing properties of nicotine are inherently linked to the way it works by ...